Intrapartum Group-B-Streptococcus Molecular Screening Cost-Effective Intrapartum Group-B-Streptococcus Molecular Screening Cost-Effective

Point-of-care intrapartum group B streptococcus (GBS) PCR testing cost-effectively reduces disease rates and antibiotic use in newborns, researchers from France report.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news